O319 A novel oral contraceptive comprising estradiol valerate/dienogest for the treatment of heavy and/or prolonged menstrual bleeding without organic cause: a double‐blind, randomised, placebo‐controlled trial
article
OA: closed
CC0
⤵ 4 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This double-blind, randomized, placebo-controlled trial investigated a novel oral contraceptive containing estradiol valerate/dienogest for treating heavy and/or prolonged menstrual bleeding without an organic cause.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (4)
- Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest 2010
- Estradiol Valerate/Dienogest: A Novel Combined Oral Contraceptive 2011
- Estradiol valerate and dienogest: a new approach to oral contraception 2011
- Treatment of heavy menstrual bleeding with a new combination of estradiol valerate and dienogest 2010
Cited by (4)
- Estradiol Valerate/Dienogest: A Novel Combined Oral Contraceptive 2011
- Estradiol valerate and dienogest: a new approach to oral contraception 2011
- Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest 2010
- Treatment of heavy menstrual bleeding with a new combination of estradiol valerate and dienogest 2010
Source provenance
- openalex
- last seen: 2026-05-10T11:23:21.415031+00:00
License: CC0
· commercial use OK